Full Press Release Details
Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform.
BIIB
Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform
Key Takeaway: Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform
Price reaction · baseline $206.89 (2022-06-21 close) · hit after-hours · clean, no other BIIB news in the window
day 0 close
+0.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis